THE TUMOR IMMUNE MICROENVIRONMENT AS A KEY DETERMINANT OF DISEASE PROGRESSION AND THERAPEUTIC RESPONSE IN HPV-ASSOCIATED CERVICAL CANCER

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Rajabova Nodira Makhmud kizi, Karimova Nargiza Mansurovna
DOI: 10.5281/zenodo.18193829
Cited by: 0

Abstract

This thesis synthesizes current concepts of HPV-driven immune remodeling across disease stages, highlights TIME features associated with progression and outcome, and discusses actionable translational strategies—including biomarker-guided immunotherapy combinations, microenvironment reprogramming, and multi-omics profiling—to improve responses and durability of control.

Fields of Study & Subjects

Cervical Cancer and HPV Research Cancer Immunotherapy and Biomarkers Endometrial and Cervical Cancer Treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
9 January 2026